Literature DB >> 17344328

The delay of contrast arrival in magnetic resonance first-pass perfusion imaging: a novel non-invasive parameter detecting collateral-dependent myocardium.

O M Muehling1, A Huber, C Cyran, S O Schoenberg, M Reiser, G Steinbeck, M Nabauer, M Jerosch-Herold.   

Abstract

AIM: To establish the regional delay of contrast arrival in magnetic resonance perfusion imaging (MRPI) for the detection of collateral-dependent myocardium in patients with coronary artery disease. DESIGN AND
SETTING: Observational study, case series; single centre, university hospital. PATIENTS: 30 patients with coronary artery disease and collateral-dependent myocardium and 17 healthy volunteers.
METHODS: Resting and hyperaemic (adenosine) MRPI was used to determine the delay time (Deltat(d)) of contrast arrival between the left ventricle and collateral-dependent or antegradely perfused myocardium, and myocardial perfusion (MP, ml/min/g).
RESULTS: In healthy volunteers, mean (SD) Deltat(d) at rest and during hyperaemia were 0.8 (0.4) and 0.3 (0.3) s, and MP was 1.14 (0.21) and 4.23 (1.12) ml/min/g. In patients Deltat(d) in antegradely perfused vs collateral-dependent myocardium was 0.9 (0.7) vs 1.7 (1.0) s at rest (p<0.001), and 0.4 (0.3) vs 1.1 (0.6) s (p<0.001) during hyperaemia. MP was 1.12 (0.11) and 0.98 (0.28) ml/min/g (p = NS) at rest and 2.46 (0.85) vs 1.86 (0.91) ml/min/g (p<0.01) during hyperaemia. Receiver operating characteristics analysis showed the best sensitivity and specificity of 90% and 83% for hyperaemic Deltat(d) of >0.6 s (area under the curve (AUC) = 0.89) to detect collateral-dependent myocardium, while resting Deltat(d) (AUC = 0.77) and perfusion (AUC = 0.69 at rest or 0.70 during hyperaemia) were less accurate.
CONCLUSIONS: MRPI-derived hyperaemic delay of contrast arrival detects collateral-dependent myocardium with high sensitivity and specificity. Perfusion was less sensitive, emphasising the clinical role of Deltat(d) in non-invasive detection of collateral-dependent myocardium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344328      PMCID: PMC1994443          DOI: 10.1136/hrt.2006.103788

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  18 in total

1.  Quantitative magnetic resonance first-pass perfusion analysis: inter- and intraobserver agreement.

Authors:  O M Mühling; M E Dickson; A Zenovich; Y Huang; B V Wilson; R F Wilson; I S Anand; R T Seethamraju; M Jerosch-Herold; N M Wilke
Journal:  J Cardiovasc Magn Reson       Date:  2001       Impact factor: 5.364

2.  Increased heterogeneity of coronary perfusion in patients with early coronary atherosclerosis.

Authors:  H Wieneke; A Schmermund; J Ge; C Altmann; M Haude; C Von Birgelen; D Baumgart; O Dirsch; R Erbel
Journal:  Am Heart J       Date:  2001-10       Impact factor: 4.749

Review 3.  The human coronary collateral circulation.

Authors:  Christian Seiler
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

4.  Time delay for arrival of MR contrast agent in collateral-dependent myocardium.

Authors:  Michael Jerosch-Herold; Xudong Hu; Naveen S Murthy; Ravi T Seethamraju
Journal:  IEEE Trans Med Imaging       Date:  2004-07       Impact factor: 10.048

5.  Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion.

Authors:  J F Hansen
Journal:  Am Heart J       Date:  1989-02       Impact factor: 4.749

6.  Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve.

Authors:  K L Gould; K Lipscomb; G W Hamilton
Journal:  Am J Cardiol       Date:  1974-01       Impact factor: 2.778

7.  The coronary collateral circulation in living man.

Authors:  G G Gensini; B C Bruto da Costa
Journal:  Am J Cardiol       Date:  1969-09       Impact factor: 2.778

8.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

9.  Influence of coronary collateral blood flow on the development of exertional ischemia and Q wave infarction in patients with severe single-vessel disease.

Authors:  S B Freedman; R F Dunn; L Bernstein; J Morris; D T Kelly
Journal:  Circulation       Date:  1985-04       Impact factor: 29.690

10.  Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects.

Authors:  K P Rentrop; M Cohen; H Blanke; R A Phillips
Journal:  J Am Coll Cardiol       Date:  1985-03       Impact factor: 24.094

View more
  5 in total

1.  Collaterals: how important are they?

Authors:  Gerald S Werner
Journal:  Heart       Date:  2007-07       Impact factor: 5.994

Review 2.  Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.

Authors:  June Yun; Petra Rocic; Yuh Fen Pung; Souad Belmadani; Ana Catarina Ribeiro Carrao; Vahagn Ohanyan; William M Chilian
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

3.  Permanent coronary artery occlusion: cardiovascular MR imaging is platform for percutaneous transendocardial delivery and assessment of gene therapy in canine model.

Authors:  Maythem Saeed; Alastair Martin; Alexis Jacquier; Matthew Bucknor; David Saloner; Loi Do; Philip Ursell; Hua Su; Yuet W Kan; Charles B Higgins
Journal:  Radiology       Date:  2008-09-09       Impact factor: 11.105

Review 4.  [Screening in cardiovascular diseases].

Authors:  H Kramer; S Weckbach; G van Kaick; M F Reiser; S O Schoenberg
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

5.  Direct Comparison of Bayesian and Fermi Deconvolution Approaches for Myocardial Blood Flow Quantification: In silico and Clinical Validations.

Authors:  Clément Daviller; Timothé Boutelier; Shivraman Giri; Hélène Ratiney; Marie-Pierre Jolly; Jean-Paul Vallée; Pierre Croisille; Magalie Viallon
Journal:  Front Physiol       Date:  2021-04-12       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.